ArticlePloS one2026
Broad immunogenicity of house dust mite proteins contrasts restricted specific IgE and IgG4 associated with allergy.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of house dust mite allergen immunotherapy in allergic rhinitis: a network meta-analysis based on component-resolved classification.Frontiers in immunology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHouse dust mite (HDM) allergy involves IgE and TH2 responses to major and minor allergens. Less is known about the involvement of other immune pathways and the potential role of other HDM proteins in allergic disease. In this study, the association between HDM allergy and immune responses to the HDM proteome was investigated.
methodsThe HDM proteome was represented by 40 purified recombinant HDM proteins (19 known allergens and 21 novel proteins). T-cell responses to HDM proteins were determined ex vivo and antibody responses (IgA, IgE, IgG and IgG4) were measured using micro arrays and basophil activation in 21 HDM allergic donors and 16 non-allergic controls. Changes in specific IgE, IgG and IgG4 during SQ HDM SLIT-Tablet immunotherapy was assessed in 38 subjects with allergic asthma.
resultsHDM proteins were broadly immunogenic inducing comparable IgG, IgA, and non-TH2 cytokine responses in both allergic and non-allergic individuals. Specific IgE, IgG4 and TH2 cytokine responses were largely restricted to the allergic donors. IgE and IgG4 were primarily directed to known major allergens and overlapping in specificity whereas cellular TH2 responses extended beyond the known HDM allergens. Individual proteins displayed distinct immunological profiles. HDM sublingual immunotherapy increased the levels of specific IgE and IgG4 but did not change the overall pattern of recognition.
conclusionHDM proteins are highly immunogenic and give rise to complex patterns of immune recognition also in the absence of allergy. This has potential implications for the pathogenesis of HDM allergy and the mode of action of allergy immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.